New vaccine trial aims to train body to attack lung cancer
NCT ID NCT01720836
Summary
This study is testing a vaccine designed to teach the body's immune system to recognize and fight non-small cell lung cancer. It is for patients with early-stage or locally advanced lung cancer who have recently finished standard treatment. The main goal is to see if the vaccine safely causes a strong immune response against the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UPMC Hillman Cancer Center
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
Conditions
Explore the condition pages connected to this study.